#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Budenofalk Uno 9 mg gastro‑resistant granules


Authors: M. Lukáš
Authors‘ workplace: Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a.  s. a Ústav lékařské bio­chemie a laboratorní dia­gnostiky 1. LF UK a VFN v Praze
Published in: Gastroent Hepatol 2015; 69(4): 392-393
Category: Drug Profile
doi: https://doi.org/10.14735/amgh2015392


Sources

1. Souhrn údajů o přípravku. Budenofalk Uno 9 mg enterosolventní granule, Sp. zn. sukls82708 2014.

2. Dignass A, Stoynoiv S, Dorofeyev AE et al. Once versus three times daily dos­ing of oral budesonide for active Crohn’s disease: a double‑blind, double‑dum­­my, randomised trial. J Crohns Colitis 2014; 8(9): 970– 980. doi: 10.1016/ j.crohns. 2014. 01.021.

3. Miehlke S, Madisch A, Kupcinskas L et al. Budesonide is more effective than mesalamine or placebo in short‑term treatment of collagenous colitis. Gastroenterology 2014; 146(5): 1222– 1230. doi: 10.1053/ j.gastro.2014.01.019.

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery

Article was published in

Gastroenterology and Hepatology

Issue 4

2015 Issue 4

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#